News
Beckman Coulter Diagnostics announced the launch of Prostate Health Index (phi), a non-invasive blood test for detecting prostate cancer.
News
For men with metastatic prostate cancer, the incidence of germline mutations in genes associated with DNA-repair processes is 11.8%, according to a study published online July 6 in The New England Journal of Medicine.
News
The USPSTF performed a systematic review of the existing evidence and concluded that the potential benefits and harms of prostate-specific antigen (PSA)-based screening are "closely balanced" in men aged 55-69 years.
News
Beckman Coulter Inc. announced that the FDA has approved Prostate Health Index (phi), a non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10ng/mL range and is proven to reduce the number of prostate biopsies.
News
Researchers from Brigham and Women's Hospital concluded that patients' race significantly affects their longevity by increasing mortality risk after receiving androgen deprivation therapy (ADT).
News
The approval was based on data from the phase 2/3 OSPREY and phase 3 CONDOR trials that evaluated the diagnostic performance and safety of Pylarify injection.
News
The approval was based on efficacy and safety data from 2 prospective clinical trials.
Drug News
An enzyme commonly used as a target for antidepressants may also promote prostate cancer growth, according to an international team of scientists.
News
The new guideline includes 22 recommendations focused on utilizing common surgical techniques and minimally invasive surgical therapies.
News, Safety Alerts and Recalls
The FDA has concluded that the use of entacapone to treat Parkinson disease (PD) does not increase the risk of developing prostate cancer.